Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />268.1 (4) codeine methylbromide; <br />268.2 (5) codeine-n-oxide; <br />268.3 (6) cyprenorphine; <br />268.4 (7) desomorphine; <br />268.5 (8) dihydromorphine; <br />268.6 (9) drotebanol; <br />268.E (10) eorphine; <br />268.8 (11) heroin; <br />268.9 (12) hydromorphinol, <br />268.10 (13) methyldesorphine; <br />268.11 (14) methyldihydromorphine; <br />268.12 (15) morphine methylbromide; <br />268.13 (16) morphine methylsulfonate; <br />268.14 (17) morphine-n-oxide; <br />268.15 (18) myrophine; <br />268.16 (19) nicocodeine; <br />268.17 (20) nicomorphine; <br />268.18 (21) normorphine; <br />268.19 (22) pholcodine; and <br />268.20 (23) thebacon. <br />268.21 (d) Hallucinogens. Any material, compound, mixture or preparation which contains any <br />268.22 quantity of the following substances, their analogs, salts, isomers (whether optical, positional, <br />268.23 or geometric), and salts of isomers, unless specifically excepted or unless listed in another <br />268.24 schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is <br />268.25 possible: <br />268.26 (1) methylenedioxy amphetamine; <br />268.27 (2) methylenedioxymethamphetamine; <br />268.28 (3) methylenedioxy-N-ethylamphetamine (MDEA); <br />Article 8 Section 1. 268 <br />